Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.290
0.00 (0.00%)
At close: Jun 5, 2025, 4:00 PM
1.280
-0.010 (-0.78%)
After-hours: Jun 5, 2025, 5:02 PM EDT

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $283.26 million as of June 5, 2025. Its market cap has decreased by -51.02% in one year.

Market Cap
283.26M
Enterprise Value
91.04M
1-Year Change
-51.02%
Ranking
Category
Stock Price
$1.29

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $283.26M, a decrease of -90.17%. That is a compound annual growth rate of -29.44%.

History

DateMarket Cap% Change
Jun 4, 2025282.16M-36.82%
Dec 31, 2024446.60M-17.32%
Dec 29, 2023540.17M-40.45%
Dec 30, 2022907.08M-57.34%
Dec 31, 20212.13B-39.95%
Dec 31, 20203.54B11.80%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 684.94B
Johnson & Johnson 368.90B
AbbVie 331.62B
Novo Nordisk 324.15B
UnitedHealth Group 270.36B
Abbott Laboratories 232.08B
Novartis AG 229.87B
AstraZeneca 226.47B
Market Cap Rankings